Clinical Trials Directory

Trials / Unknown

UnknownNCT03352739

Fornix and NbM as Targets of Stimulation In Alzheimer's Disease

A Randomized Controlled Study of 12 Months to Evaluate the Safety and Efficacy of Deep Brain Stimulation(DBS) to the Fornix & Meynert Nucleus(NbM) in Patients With Mild to Moderate Alzheimer's Disease(AD)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
45 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The primary goal of this study is to evaluate the efficacy and safety of the DBS to the fornix/NbM among patients who are diagnosed as AD according to a series of evaluations including cerebrospinal fluid (CSF) biomarkers and molecular imaging examinations; The secondary goal is to compare the efficacy among the two treatment groups of different targets.

Conditions

Interventions

TypeNameDescription
DEVICEDBS of the fornix, power onDBS of bilateral columns of the fornix is performed, with the power of the device on since the 1st month after the implantation. Observations will start at the time when the device is turning on . DBS system includes: Pins G102 Implantable Neurostimulator; Pins L301 DBS Electrode; Pins E202 DBS extension lead
DEVICEDBS of the NbM, power onDBS of bilateral NbMs is performed, with the power of the device on since the 1st month after the implantation. Observations will start at the time when the device is turning on . DBS system includes: Pins G102 Implantable Neurostimulator; Pins L301 DBS Electrode; Pins E202 DBS extension lead
DEVICEDBS of the fornix, power offDBS of bilateral columns of the fornix is performed, the power of the device is going to keep off during the first 7 months after the implantation. Observations will start after 1 month of the implantation. DBS system includes: Pins G102 Implantable Neurostimulator; Pins L301 DBS Electrode; Pins E202 DBS extension lead
DEVICEDBS of the NbM, power offDBS of bilateral NbMs is performed, the power of the device is going to keep off during the first 7 months after the implantation. Observations will start after 1 month of the implantation. DBS system includes: Pins G102 Implantable Neurostimulator; Pins L301 DBS Electrode; Pins E202 DBS extension lead

Timeline

Start date
2017-12-01
Primary completion
2019-12-01
Completion
2020-12-01
First posted
2017-11-24
Last updated
2018-01-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03352739. Inclusion in this directory is not an endorsement.